Skip to content

Sunday, October 6, 2024

Canadian Stock Trader

Canadian Stocks

Search

Home
Crypto
HeadLines
Stock News
Canadian Stock Trader

Home
Stock News
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology

Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology

September 30, 2024

Related

Post navigation

Alphabet executive John Kent Walker sells $2.78 million in stock

UBiqube Strengthens Board with Cloud and Security Veterans to Drive AgileOps Vision and Global Expansion

Start your own business

Are you an aspiring entrepreneur who is ready to take that great idea and turn it into a business?

you’ll learn how to choose a business name, pick the perfect domain name for your business, build a website and more!

Canadian Stock Trader

Home
Crypto
HeadLines
Stock News
Canadian Stock Trader

Biotech Canada Canadian Cannabis Dow jones For Sale Investor Market News Product STOCKS TMX TSX ZIFI

Copyright © 2024 Canadian Stock Trader

Theme by: Theme Horse

Proudly Powered by: WordPress